4.8 Article

Month of birth, vitamin D and risk of immune-mediated disease: a case control study

Journal

BMC MEDICINE
Volume 10, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1741-7015-10-69

Keywords

-

Funding

  1. FISM-Fondazione Italiana Sclerosi Multipla-Cod. [2010/B/5]
  2. Medical Research Council [G0801976]
  3. Wellcome Trust [090532/Z/09/Z]
  4. MS Society of Australia
  5. Bayer Schering Pharma
  6. Biogen Idec
  7. Merck Serono
  8. Novartis
  9. UCB
  10. Merz Pharmaceuticals, LLC
  11. Teva Pharmaceutical Industries Ltd-sanofiaventis
  12. GW Pharma
  13. Ironwood
  14. MRC
  15. NHS Executive
  16. sanofiaventis
  17. Roche
  18. Multiple Sclerosis Society of the United Kingdom
  19. Multiple Sclerosis Society of Canada Scientific Research Foundation
  20. Medical Research Council [G0801976, G0400546B, G0400546, G0801975] Funding Source: researchfish
  21. National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish
  22. MRC [G0801975, G0400546, G0801976] Funding Source: UKRI

Ask authors/readers for more resources

Background: A season of birth effect in immune-mediated diseases (ID) such as multiple sclerosis and type 1 diabetes has been consistently reported. We aimed to investigate whether season of birth influences the risk of rheumatoid arthritis, Crohn's disease, ulcerative colitis and systemic lupus erythematosus in addition to multiple sclerosis, and to explore the correlation between the risk of ID and predicted ultraviolet B (UVB) light exposure and vitamin D status during gestation. Methods: The monthly distribution of births of patients with ID from the UK (n = 115,172) was compared to that of the general population using the Cosinor test. Predicted UVB radiation and vitamin D status in different time windows during pregnancy were calculated for each month of birth and correlated with risk of ID using the Spearman's correlation coefficient. Results: The distributions of ID births significantly differed from that of the general population (P = 5e(-12)) with a peak in April (odds ratio = 1.045, 95% confidence interval = 1.024, 1.067, P < 0.0001) and a trough in October (odds ratio = 0.945, 95% confidence interval = 0.925, 0.966, P < 0.0001). Stratification by disease subtype showed seasonality in all ID but Crohn's disease. The risk of ID was inversely correlated with predicted second trimester UVB exposure (Spearman's rho = -0.49, P = 0.00005) and third trimester vitamin D status (Spearman's rho = -0.44, P = 0.0003). Conclusions: The risk of different ID in the UK is significantly influenced by the season of birth, suggesting the presence of a shared seasonal risk factor or factors predisposing to ID. Gestational UVB and vitamin D exposure may be implicated in the aetiology of ID.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available